Skip to Main Content

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

Conditions

Addictive Behaviors | Obesity & Weight Control

Phase II-III

What is the purpose of this trial?

This study will test the effectiveness and relative efficacy of behavioral and pharmacologic treatments, alone and in combination, for the treatment of binge eating disorder (BED) in patients with obesity. This is an acute treatment comparing behavioral weight loss alone or in combination with naltrexone/bupropion medication.

  • Ages
    18 years - 70 years
  • Gender
    Both
Find out more about who can participate in this trial
  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
  • Start Date
    02/27/2017
  • End Date
    10/31/2023

For more information about this study, contact:

Janet Lydecker

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Sub-Investigators

  • Last Updated
    07/15/2021
  • Study HIC
    #1506016065

Contact Information

For more information about this study, including how to volunteer, contact Janet Lydecker

Volunteer Now